PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-305.00%
Negative net income growth while BTE stands at 11.46%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
1.03%
Some D&A expansion while BTE is negative at -57.09%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-245.73%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-25.56%
Both reduce yoy usage, with BTE at -431.06%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.56%
Negative yoy usage while BTE is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
10.26%
Lower 'other non-cash' growth vs. BTE's 34.75%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-16.98%
Negative yoy CFO while BTE is 5.65%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
16.40%
Lower CapEx growth vs. BTE's 36.52%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
38350.00%
Less M&A spending yoy vs. BTE's 209568.18%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
100.00%
Purchases growth of 100.00% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-100.00%
We reduce yoy sales while BTE is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
61.77%
We have some outflow growth while BTE is negative at -1776.98%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
106.38%
Investing outflow well above BTE's 55.37%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
6.98%
Debt repayment growth of 6.98% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.